HMGB1-mediated radioresistance in ESCC involves PI3K/AKT/ATM pathway activation (49), and ATM polymorphisms may serve as predictors of radiation therapy outcomes (50). This evidence concerns the gene AKT1 and esophageal squamous cell carcinoma.